Abstract
The files of 183 elderly patients aged >70 years, with localized prostate cancer (T1-3, N0-X, M0), treated with radical external radiation therapy (ERT) from January 1992 to December 2001 at the Radiotherapy Department of the Istituto Nazionale Tumori of Milan, were reviewed. Median age was 75 years. ERT represented the sole treatment for 73 patients (39.9%); in 110 cases (60.1%) hormonal therapy (HT) was associated with neoadjuvant intent. Five-year overall, disease-specific and biochemical NED (bNED) survival rates were 90.2, 93.7 and 63.2%, respectively. A subset of 23 patients aged 80 years and over were analyzed and compared to 160 men aged 70-79 years. Acute toxicity and late complications were analyzed in the two groups of patients according to the RTOG scoring system. Only 10 patients (5.4%) showed grades 2-3 (G2-3) late sequelae. The results obtained in this single-institute series highlight the pivotal role of ERT in the management of clinically localized prostate cancer in the elderly.
| Original language | English |
|---|---|
| Pages (from-to) | 215-225 |
| Number of pages | 11 |
| Journal | Critical Reviews in Oncology/Hematology |
| Volume | 48 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Nov 2003 |
Fingerprint
Keywords
- Elderly
- Prostate cancer
- Radiation therapy
ASJC Scopus subject areas
- Cancer Research
- Hematology
- Oncology
Cite this
External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma : Age is not a problem. / Villa, Sergio; Bedini, Nice; Fallai, Carlo; Olmi, Patrizia.
In: Critical Reviews in Oncology/Hematology, Vol. 48, No. 2, 11.2003, p. 215-225.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma
T2 - Age is not a problem
AU - Villa, Sergio
AU - Bedini, Nice
AU - Fallai, Carlo
AU - Olmi, Patrizia
PY - 2003/11
Y1 - 2003/11
N2 - The files of 183 elderly patients aged >70 years, with localized prostate cancer (T1-3, N0-X, M0), treated with radical external radiation therapy (ERT) from January 1992 to December 2001 at the Radiotherapy Department of the Istituto Nazionale Tumori of Milan, were reviewed. Median age was 75 years. ERT represented the sole treatment for 73 patients (39.9%); in 110 cases (60.1%) hormonal therapy (HT) was associated with neoadjuvant intent. Five-year overall, disease-specific and biochemical NED (bNED) survival rates were 90.2, 93.7 and 63.2%, respectively. A subset of 23 patients aged 80 years and over were analyzed and compared to 160 men aged 70-79 years. Acute toxicity and late complications were analyzed in the two groups of patients according to the RTOG scoring system. Only 10 patients (5.4%) showed grades 2-3 (G2-3) late sequelae. The results obtained in this single-institute series highlight the pivotal role of ERT in the management of clinically localized prostate cancer in the elderly.
AB - The files of 183 elderly patients aged >70 years, with localized prostate cancer (T1-3, N0-X, M0), treated with radical external radiation therapy (ERT) from January 1992 to December 2001 at the Radiotherapy Department of the Istituto Nazionale Tumori of Milan, were reviewed. Median age was 75 years. ERT represented the sole treatment for 73 patients (39.9%); in 110 cases (60.1%) hormonal therapy (HT) was associated with neoadjuvant intent. Five-year overall, disease-specific and biochemical NED (bNED) survival rates were 90.2, 93.7 and 63.2%, respectively. A subset of 23 patients aged 80 years and over were analyzed and compared to 160 men aged 70-79 years. Acute toxicity and late complications were analyzed in the two groups of patients according to the RTOG scoring system. Only 10 patients (5.4%) showed grades 2-3 (G2-3) late sequelae. The results obtained in this single-institute series highlight the pivotal role of ERT in the management of clinically localized prostate cancer in the elderly.
KW - Elderly
KW - Prostate cancer
KW - Radiation therapy
UR - http://www.scopus.com/inward/record.url?scp=0242352371&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0242352371&partnerID=8YFLogxK
U2 - 10.1016/j.critrevonc.2003.05.006
DO - 10.1016/j.critrevonc.2003.05.006
M3 - Article
C2 - 14607384
AN - SCOPUS:0242352371
VL - 48
SP - 215
EP - 225
JO - Critical Reviews in Oncology/Hematology
JF - Critical Reviews in Oncology/Hematology
SN - 1040-8428
IS - 2
ER -